News
New influx of Humira biosimilars may not drive immediate change
As many as 8-10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Humira some vigorous competition.
News
New influx of Humira biosimilars may not drive immediate change
As many as 8-10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Humira some vigorous competition.
News
Setting higher standards for digital health technologies
“There really isn’t a streamlined way to know, as a clinician or as a patient, which [health technologies] really make a difference clinically and...
News
Teamwork guides cardio-rheumatology clinics that care for unique patient population
Cardio-rheumatology programs are “the newest child” in a series of cardiology offshoots focusing on different populations, and such clinics aim to...
News
Miami hepatologist leverages Golden Rule to balance work, family, address health equities
“Showing my kids how important it is to help and serve others is one of the best legacies I can leave them.”
News
Rheumatology Match Day follows same pattern as previous years
Pediatric rheumatology didn’t do as well as adult programs, filling just 18 of 32 certified programs (56.3%) and 27 out of 43 certified positions...
News
Research fails to justify post-COVID-19 wave of new-onset parkinsonism
While cases have been reported, current data do not yet justify the concept of a post–COVID-19 parkinsonism wave.
News
Sex differences seen in inflammatory arthritis health care use
Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher...
News
Hormones’ impact described in transgender rheumatology patients
Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new...
News
Severe COVID-19–related outcomes found worse in men with RA
A retrospective study of patients with rheumatoid arthritis and COVID-19 showed that men had more baseline comorbidities and increased risk of...
News
COVID vaccination does not appear to worsen symptoms of Parkinson’s disease
Vaccination programs should continue for patients with Parkinson’s disease.
News
Telehealth effective in managing patients with movement disorders
“These studies ... demonstrate that we are only scratching the surface of the telehealth’s potential to improve care and the lives of individuals...
News
Medical cannabis appears safe for patients with movement disorders
Medical cannabis for patients with Parkinson’s disease or Huntington’s disease should be done with careful monitoring.
News
Novel combination treatment improves function in early Parkinson’s disease
P2B001 – a proprietary, fixed-dose combination of extended-release pramipexole and rasagiline – improved motor symptoms and daily functioning.
News
OMERACT continues to set standards on research outcomes, enhancing the patient voice
OMERACT arose from a need to streamline clinical outcome measures in rheumatology, and now with 30 years of...